Annual Report 2004 of Beximco Pharmaceuticals Limited

It is a broadly described annual report of Beximco Pharmaceuticals Limited in the year of 2004. During 2004, Beximco Pharma contributed Tk. 534.31 million in the form of import-related taxes, VAT and Income tax to the national exchequer. The company achieved net sales of Tk. 2,402.70 million in 2004 over Tk. 2,183.83 million in 2003. Overall growth in sales is, however, 10% on a comparable basis. The rate of gross profit has improved by 2.54%. The Pre-tax Profit also increased on a comparable basis. The Net Profit before tax in 2004 was Tk. 318.59 million as compared to Tk. 263.62 million in 2003. This reflects an appreciable 20.85% increase.

The Board of Directors has recommended 5% cash dividend and 25% stock dividend (Bonus Share) for shareholders approval for the year ended 31st December 2004. These financial statements are presented in Bangladesh Taka (Taka/Tk/BDT) which is the company’s functional currency. All financial information presented in Taka has been rounded off to the nearest Taka.

More Annual Report of Beximco Pharmaceuticals Limited :

  1. Annual Report 2001 of Beximco Pharmaceuticals Limited
  2. Annual Report 2002 of Beximco Pharmaceuticals Limited
  3. Annual Report 2003 of Beximco Pharmaceuticals Limited
  4. Annual Report 2004 of Beximco Pharmaceuticals Limited
  5. Annual Report 2005 of Beximco Pharmaceuticals Limited
  6. Annual Report 2006 of Beximco Pharmaceuticals Limited
  7. Annual Report 2007 of Beximco Pharmaceuticals Limited
  8. Annual Report 2008 of Beximco Pharmaceuticals Limited
  9. Annual Report 2009 of Beximco Pharmaceuticals Limited
  10. Annual Report 2010 of Beximco Pharmaceuticals Limited
  11. Annual Report 2011 of Beximco Pharmaceuticals Limited
  12. Annual Report 2012 of Beximco Pharmaceuticals Limited
  13. Annual Report 2013 of Beximco Pharmaceuticals Limited
  14. Annual Report 2014 of Beximco Pharmaceuticals Limited
  15. Auditors’ Report 2015 of Beximco Pharmaceuticals Limited
  16. Annual Report 2016 of Beximco Pharmaceuticals Limited
  17. Auditors’ Report 2017 of Beximco Pharmaceuticals Limited